Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
Steven M. Opal, Pierre‐François Laterre, Bruno François, Steven P. LaRosa, Derek C. Angus, Jean‐Paul Mira, Xavier Wittebole, Thierry Dugernier, D. Perrotin, Mark Tidswell, Luis Jáuregui, Kenneth Krell, Jan Pachl, Takeshi Takahashi, C. Peckelsen, Edward M. Cordasco, Chia-Sheng Chang, Sandra Oeyen, Naoki Aikawa, Tatsuya Maruyama, Roland M.H. Schein, André C. Kalil, Marc Van Nuffelen, Melvyn Lynn, Daniel P. Rossignol, Jagadish Gogate, Mary B. Roberts, Janice L. Wheeler, Jean Louis Vincent, for the ACCESS Study Group (2013). Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis. , 309(11), DOI: https://doi.org/10.1001/jama.2013.2194.
